Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 132

1.

A model of reoxygenation dynamics of head-and-neck tumors based on serial 18F-fluoromisonidazole positron emission tomography investigations.

Thorwarth D, Eschmann SM, Paulsen F, Alber M.

Int J Radiat Oncol Biol Phys. 2007 Jun 1;68(2):515-21. Epub 2007 Mar 29.

PMID:
17398015
2.

Kinetic analysis of dynamic 18F-fluoromisonidazole PET correlates with radiation treatment outcome in head-and-neck cancer.

Thorwarth D, Eschmann SM, Scheiderbauer J, Paulsen F, Alber M.

BMC Cancer. 2005 Dec 1;5:152.

3.

The influence of changes in tumor hypoxia on dose-painting treatment plans based on 18F-FMISO positron emission tomography.

Lin Z, Mechalakos J, Nehmeh S, Schoder H, Lee N, Humm J, Ling CC.

Int J Radiat Oncol Biol Phys. 2008 Mar 15;70(4):1219-28. doi: 10.1016/j.ijrobp.2007.09.050.

4.

Fluorine-18-labeled fluoromisonidazole positron emission and computed tomography-guided intensity-modulated radiotherapy for head and neck cancer: a feasibility study.

Lee NY, Mechalakos JG, Nehmeh S, Lin Z, Squire OD, Cai S, Chan K, Zanzonico PB, Greco C, Ling CC, Humm JL, Schöder H.

Int J Radiat Oncol Biol Phys. 2008 Jan 1;70(1):2-13. Epub 2007 Sep 14.

5.

The reoxygenation of hypoxia and the reduction of glucose metabolism in head and neck cancer by fractionated radiotherapy with intensity-modulated radiation therapy.

Okamoto S, Shiga T, Yasuda K, Watanabe S, Hirata K, Nishijima KI, Magota K, Kasai K, Onimaru R, Tuchiya K, Kuge Y, Shirato H, Tamaki N.

Eur J Nucl Med Mol Imaging. 2016 Nov;43(12):2147-2154. Epub 2016 Jun 1.

PMID:
27251644
6.

Reproducibility of intratumor distribution of (18)F-fluoromisonidazole in head and neck cancer.

Nehmeh SA, Lee NY, Schröder H, Squire O, Zanzonico PB, Erdi YE, Greco C, Mageras G, Pham HS, Larson SM, Ling CC, Humm JL.

Int J Radiat Oncol Biol Phys. 2008 Jan 1;70(1):235-42.

7.

Prospective trial incorporating pre-/mid-treatment [18F]-misonidazole positron emission tomography for head-and-neck cancer patients undergoing concurrent chemoradiotherapy.

Lee N, Nehmeh S, Schöder H, Fury M, Chan K, Ling CC, Humm J.

Int J Radiat Oncol Biol Phys. 2009 Sep 1;75(1):101-8. doi: 10.1016/j.ijrobp.2008.10.049. Epub 2009 Feb 7.

8.

Hypoxia-imaging with (18)F-Misonidazole and PET: changes of kinetics during radiotherapy of head-and-neck cancer.

Eschmann SM, Paulsen F, Bedeshem C, Machulla HJ, Hehr T, Bamberg M, Bares R.

Radiother Oncol. 2007 Jun;83(3):406-10. Epub 2007 May 31.

PMID:
17543402
9.

Dual tracer evaluation of dynamic changes in intratumoral hypoxic and proliferative states after radiotherapy of human head and neck cancer xenografts using radiolabeled FMISO and FLT.

Fatema CN, Zhao S, Zhao Y, Yu W, Nishijima K, Yasuda K, Kitagawa Y, Tamaki N, Kuge Y.

BMC Cancer. 2014 Sep 22;14:692. doi: 10.1186/1471-2407-14-692.

10.

Comparison of (immuno-)fluorescence data with serial [¹⁸F]Fmiso PET/CT imaging for assessment of chronic and acute hypoxia in head and neck cancers.

Maftei CA, Shi K, Bayer C, Astner ST, Vaupel P.

Radiother Oncol. 2011 Jun;99(3):412-7. doi: 10.1016/j.radonc.2011.05.079. Epub 2011 Jun 28.

PMID:
21719136
11.

Hypoxia-targeted radiotherapy dose painting for head and neck cancer using (18)F-FMISO PET: a biological modeling study.

Chang JH, Wada M, Anderson NJ, Lim Joon D, Lee ST, Gong SJ, Gunawardana DH, Sachinidis J, O'Keefe G, Gan HK, Khoo V, Scott AM.

Acta Oncol. 2013 Nov;52(8):1723-9. doi: 10.3109/0284186X.2012.759273. Epub 2013 Jan 15.

PMID:
23317145
12.

The Effects of Pulsed Radiation Therapy on Tumor Oxygenation in 2 Murine Models of Head and Neck Squamous Cell Carcinoma.

Wobb J, Krueger SA, Kane JL, Galoforo S, Grills IS, Wilson GD, Marples B.

Int J Radiat Oncol Biol Phys. 2015 Jul 15;92(4):820-8. doi: 10.1016/j.ijrobp.2015.04.002. Epub 2015 Apr 12.

PMID:
26104936
13.

Hypoxia imaging with [18F]-FMISO-PET for guided dose escalation with intensity-modulated radiotherapy in head-and-neck cancers.

Henriques de Figueiredo B, Zacharatou C, Galland-Girodet S, Benech J, De Clermont-Gallerande H, Lamare F, Hatt M, Digue L, De Mones del Pujol E, Fernandez P.

Strahlenther Onkol. 2015 Mar;191(3):217-24. doi: 10.1007/s00066-014-0752-8. Epub 2014 Sep 23.

PMID:
25245468
14.

Correlation between tumor oxygenation and 18F-fluoromisonidazole PET data simulated based on microvessel images.

Mönnich D, Troost EG, Kaanders JH, Oyen WJ, Alber M, Zips D, Thorwarth D.

Acta Oncol. 2013 Oct;52(7):1308-13. doi: 10.3109/0284186X.2013.812796. Epub 2013 Aug 29.

PMID:
23984808
15.

Prognostic impact of hypoxia imaging with 18F-misonidazole PET in non-small cell lung cancer and head and neck cancer before radiotherapy.

Eschmann SM, Paulsen F, Reimold M, Dittmann H, Welz S, Reischl G, Machulla HJ, Bares R.

J Nucl Med. 2005 Feb;46(2):253-60.

16.

High reproducibility of tumor hypoxia evaluated by 18F-fluoromisonidazole PET for head and neck cancer.

Okamoto S, Shiga T, Yasuda K, Ito YM, Magota K, Kasai K, Kuge Y, Shirato H, Tamaki N.

J Nucl Med. 2013 Feb;54(2):201-7. doi: 10.2967/jnumed.112.109330. Epub 2013 Jan 15.

17.

[18F]-Fluoromisonidazole positron emission tomography/computed tomography visualization of tumor hypoxia in patients with chordoma of the mobile and sacrococcygeal spine.

Cheney MD, Chen YL, Lim R, Winrich BK, Grosu AL, Trofimov AV, Depauw N, Shih HA, Schwab JH, Hornicek FJ, DeLaney TF.

Int J Radiat Oncol Biol Phys. 2014 Dec 1;90(5):1030-6. doi: 10.1016/j.ijrobp.2014.08.016.

18.

Noninvasive assessment of tumor microenvironment using dynamic contrast-enhanced magnetic resonance imaging and 18F-fluoromisonidazole positron emission tomography imaging in neck nodal metastases.

Jansen JF, Schöder H, Lee NY, Wang Y, Pfister DG, Fury MG, Stambuk HE, Humm JL, Koutcher JA, Shukla-Dave A.

Int J Radiat Oncol Biol Phys. 2010 Aug 1;77(5):1403-10. doi: 10.1016/j.ijrobp.2009.07.009. Epub 2009 Nov 10.

19.

Serial [18F]-fluoromisonidazole PET during radiochemotherapy for locally advanced head and neck cancer and its correlation with outcome.

Wiedenmann NE, Bucher S, Hentschel M, Mix M, Vach W, Bittner MI, Nestle U, Pfeiffer J, Weber WA, Grosu AL.

Radiother Oncol. 2015 Oct;117(1):113-7. doi: 10.1016/j.radonc.2015.09.015. Epub 2015 Sep 29.

PMID:
26432067
20.

Combined uptake of [18F]FDG and [18F]FMISO correlates with radiation therapy outcome in head-and-neck cancer patients.

Thorwarth D, Eschmann SM, Holzner F, Paulsen F, Alber M.

Radiother Oncol. 2006 Aug;80(2):151-6. Epub 2006 Aug 21.

PMID:
16920211

Supplemental Content

Support Center